Nellcor gets US nod for adhesive-free sensors:
This article was originally published in Clinica
Executive Summary
Nellcor has gained US FDA 510(k) clearance to sell its SoftCare family of adhesive-free pulse oximetry sensors, which are designed to protect the delicate skin of neonates, geriatrics and other patients with compromised skin integrity. Designed for use with the firm's OxiMax pulse oximeters and other manufacturers' multi-parameter monitoring systems equipped with the OxiMax technology, the sensors fastens around the sensor site with Velcro instead of adhesive tape to eliminate adhesive-related skin trauma. Research has shown that adhesives are the primary cause of skin breakdown among neonatal intensive care unit patients, says the Pleasanton, California firm. Pulse oximetry sensors were cited as one of the therapeutic interventions that can potentially cause skin injury.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.